Opportunities for cannabis in Cape Town’s pharmaceutical industry
Summary
The document identifies Cape Town as a potential medicinal cannabis hub, leveraging its existing pharmaceutical infrastructure and medical tourism status. It outlines opportunities across the value chain, from cultivation to agro-technology services, while noting significant barriers such as electricity instability (load shedding), financing difficulties due to licensing requirements, and a reliance on volatile international export markets.
Key insights
- The global cannabis sector was valued at $51.28 billion in 2023, and in South Africa, President Cyril Ramaphosa estimated the industry could be worth R406.3 billion and create over 130,000 new jobs by 2026.
- Investment opportunities in Cape Town extend beyond cultivation and processing to include agro-technology suppliers providing lighting, fertigation, drip irrigation, and water treatment.
- The Epping industrial zone is identified as a strategic location for medicinal cannabis start-ups due to available warehouses for indoor facilities and its proximity (approximately 6 km) to Cape Town International Airport, which facilitates exports.
- Cape Town has a competitive advantage in medical tourism due to its world-renowned doctors, English-speaking personnel, and favorable exchange rates; however, the lack of a national wellness strategy is viewed as a lost opportunity.
- Production costs vary significantly by method: indoor production has the highest capital investment cost at 807 USD/m2, followed by greenhouses (538 USD/m2) and outdoor production (108 USD/m2).
- Load shedding poses a severe risk to productivity and product quality; indoor facilities are mitigating this by investing in solar PV systems and battery storage, while greenhouse producers adjust schedules or use diesel generators.
- Financial barriers exist because the South African Health Products Regulatory Authority (SAHPRA) requires facilities to be fully set up before issuing a license, making financiers reluctant to provide funding due to the risk of license denial.
- The industry is vulnerable to international market restrictions intended to protect domestic industries in other countries, highlighting the need for trade agreements and a stronger domestic market.
Cite the original document
- APA
- GreenCape (n.d.). Opportunities for cannabis in Cape Town’s pharmaceutical industry. https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf
- Chicago
- GreenCape. Opportunities for cannabis in Cape Town’s pharmaceutical industry. n.d. https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf.
- Wikipedia
- {{cite report |author=GreenCape |title=Opportunities for cannabis in Cape Town’s pharmaceutical industry |url=https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}
- BibTeX
- @techreport{greencapendopportunities, author = {{GreenCape}}, title = {{Opportunities for cannabis in Cape Town’s pharmaceutical industry}}, institution = {GreenCape}, url = {https://greencape.co.za/wp-content/uploads/2023/06/Cape-Towns-pharmaceutical-industry.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }
Full text
Collected · Record updated